At the single-cell level, our PAX7 target gene repression biomarker is a better discriminator of FSHD versus control cells, and can even discriminate DUX4 target gene-negative FSHD cells from controls. Here, PAX7 is linked to facioscapulohumeral muscular dystrophy.